Dr. Kumar Discusses Genetic Abnormalities in Myeloma

Shaji K. Kumar, MD
Published: Tuesday, Nov 21, 2017



Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.

There has been significant progress toward understanding genetic variations in patients with multiple myeloma.

Through the use of FISH testing, abnormalities such as 17p deletion are discovered. Though there are abnormalities such as translocation present at diagnosis, these may change throughout a patient’s treatment course or when they relapse, says Kumar.


Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.

There has been significant progress toward understanding genetic variations in patients with multiple myeloma.

Through the use of FISH testing, abnormalities such as 17p deletion are discovered. Though there are abnormalities such as translocation present at diagnosis, these may change throughout a patient’s treatment course or when they relapse, says Kumar.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™: Choosing Therapies for Patients with EGFR-mutant Lung Cancers: More Options... More Decisions... Better OutcomesApr 27, 20182.0
Community Practice Connections™: 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and MyelomaApr 27, 20182.0
Publication Bottom Border
Border Publication
x